Antithrombin III Deficiency

This is a condition where the body doesn't have enough of a protein called Antithrombin III. This protein helps prevent blood clots. Without enough of it, a person is at higher risk of developing blood clots, which can cause serious health problems like stroke or heart attack. It's often inherited.

Condition

What people with Antithrombin III Deficiency report

Every report comes from a Lived member, sent anonymously.

Have you tried Coumadin (Warfarin) for Antithrombin III Deficiency?

NameHow it went

About Antithrombin III Deficiency

What It Is

Antithrombin III deficiency is an inherited condition in which the blood has too little working antithrombin, one of the body's natural anticlotting proteins. The protein is now usually just called antithrombin, so the condition is also known as hereditary antithrombin deficiency. Antithrombin normally switches off clotting proteins, especially thrombin, so that clots form only where they are needed. With less of it, blood clots more readily than it should. The main consequence is a higher chance of venous thromboembolism: a deep vein thrombosis (DVT), usually a clot in a leg vein, or a pulmonary embolism (PE), when a clot travels to the lungs. Among the inherited clotting disorders, antithrombin deficiency carries one of the highest clot risks, and clots usually first appear after adolescence. Many people feel entirely well until a clot happens, and some are diagnosed only because a relative was.

Causes & Risk Factors

The inherited form is caused by a change in the SERPINC1 gene, which carries the instructions for antithrombin. One altered copy is enough, so a parent with the condition has a 50% chance of passing it to each child. Some gene changes reduce how much antithrombin is made (type I); others produce a protein that is present but works poorly (type II). The type matters because clot risk differs between them, with some type II forms carrying a lower risk than type I. Having the condition raises the background risk, and certain situations add to it. Surgery, injury, long periods of immobility, pregnancy and the weeks after delivery, and estrogen-containing hormones such as combined birth control pills and menopausal hormone therapy all make clots more likely. Even so, a substantial share of clots in people with this condition happen without an obvious trigger. Antithrombin levels can also drop for reasons that are not inherited. A recent clot, severe illness with widespread clotting, major surgery, liver disease, kidney disease that leaks protein into the urine, estrogen therapy and asparaginase (a leukemia medicine) can all lower it temporarily. This acquired kind is more common than the inherited form.

How It's Diagnosed

Testing usually starts after an unexplained clot, a clot at a young age or in an unusual place (such as veins in the abdomen or brain), or a known diagnosis in the family. The key test is an antithrombin activity blood test, which measures how well a person's antithrombin blocks clotting compared with a healthy reference. Results are given as a percentage of normal: roughly 80% to 120% is typical, and levels persistently below about 70% to 80% suggest deficiency. Exact cutoffs differ between laboratories, and babies under 6 months have naturally lower levels. Timing matters. A fresh clot, heparin and some blood-thinning pills can push results falsely down or up, and acquired causes are common, so a low result is usually repeated once those factors are out of the way. A second test of the amount of antithrombin protein (the antigen test) helps tell type I from type II. Genetic testing of SERPINC1 can confirm the inherited form, identify the exact change for testing relatives, and catch some type II variants that standard activity tests miss.

Treatment Options

Treatment aims to prevent clots and to treat any that occur. There is no routine therapy for someone who has never had a clot; instead, protection is added during high-risk periods. After a clot, the recurrence risk without ongoing treatment is high, so most people are advised to stay on an anticoagulant (blood thinner) long term rather than stopping after a few months. Antithrombin deficiency changes how blood thinners behave. Heparin and low-molecular-weight heparin (LMWH) injections, such as enoxaparin (Lovenox), work by boosting antithrombin, so they can be less effective when antithrombin is low, and doses may need adjusting with blood tests to confirm they are working. Oral anticoagulants, such as warfarin or a direct oral anticoagulant like apixaban or rivaroxaban, do not depend on antithrombin in the same way and are commonly used for long-term prevention, although none corrects the underlying deficiency. Antithrombin concentrate, sold in the US as Thrombate III and made from donated human plasma, replaces the missing protein. It is given as an infusion into a vein in a hospital or clinic and is approved for adults and children with the inherited condition to treat and prevent clots, including around surgery and childbirth. It is typically used for short, high-risk periods or when heparin is not working well, rather than as everyday treatment. Avoiding estrogen-containing contraception and menopausal hormone therapy is generally advised, and progestin-only or non-hormonal methods are usually preferred. Staying active, moving during long trips and planning ahead for surgery all reduce risk.

What to Expect

The course varies widely. Many people with the condition will have at least one clot in their lifetime, but some never do, and the risk depends on the type of deficiency, the antithrombin level, other inherited clotting traits and life circumstances. Most people live ordinary lives, with some extra planning. That planning centers on predictable risk periods. Before any surgery, procedure or long hospital stay, the care team and a hematologist (blood specialist) agree on a prevention plan, which may include heparin, antithrombin concentrate or both. Pregnancy needs particular care: it is generally managed with an expert team, usually with LMWH injections through pregnancy and for several weeks after delivery, with blood tests to guide dosing and sometimes antithrombin concentrate around birth. Warfarin and the newer blood-thinning pills are not used in pregnancy because they can harm the baby, so anyone taking one should plan pregnancy with their team and contact them as soon as they find out they are pregnant, so they can switch to injections. For people on long-term blood thinners, life includes regular reviews of bleeding risk, dosing and any new medicines. Because the condition runs in families, a diagnosis often prompts testing of parents, siblings and children, which can help relatives plan their own prevention before surgery, pregnancy or hormone use.

When to Seek Help

Ask about testing if you have had an unexplained clot, a clot at a young age or in an unusual place, or a close relative with antithrombin deficiency, and make sure your care team knows about the condition well before any planned surgery, pregnancy or new hormone treatment. Contact your care team right away if one leg becomes swollen, painful, warm or tender, which can signal a deep vein clot. If you take a blood thinner, also contact them about unusual or heavy bleeding. Get emergency care (call 911) for sudden shortness of breath, chest pain that worsens with a deep breath, coughing up blood, or fainting, since these can mean a clot has reached the lungs.

Questions to Ask Your Doctor

  1. 1.Do my test results show the inherited form or a temporary drop, and should they be repeated or confirmed with genetic testing?
  2. 2.Given my type of deficiency and history, should I be on a long-term blood thinner, or only protected during high-risk periods?
  3. 3.What is our plan for surgery, long travel or pregnancy, and when would antithrombin concentrate be used?
  4. 4.Which forms of contraception or hormone therapy are safe for me?
  5. 5.Which family members should be tested, and when?

Last reviewed • Oct 2026

Educational content, not medical advice.